- Home
- RFIL vs ELEV Comparison
RFIL vs ELEV Comparison
Compare RFIL & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFIL
- ELEV
- Stock Information
- Founded
- RFIL 1979
- ELEV 2019
- Country
- RFIL United States
- ELEV United States
- Employees
- RFIL N/A
- ELEV N/A
- Industry
- RFIL Electrical Products
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- RFIL Technology
- ELEV Health Care
- Exchange
- RFIL Nasdaq
- ELEV Nasdaq
- Market Cap
- RFIL 39.9M
- ELEV 37.6M
- IPO Year
- RFIL N/A
- ELEV 2021
- Fundamental
- Price
- RFIL $5.04
- ELEV $0.61
- Analyst Decision
- RFIL Strong Buy
- ELEV Buy
- Analyst Count
- RFIL 1
- ELEV 6
- Target Price
- RFIL $4.50
- ELEV $7.20
- AVG Volume (30 Days)
- RFIL 61.7K
- ELEV 1.3M
- Earning Date
- RFIL 03-17-2025
- ELEV 03-05-2025
- Dividend Yield
- RFIL N/A
- ELEV N/A
- EPS Growth
- RFIL N/A
- ELEV N/A
- EPS
- RFIL N/A
- ELEV N/A
- Revenue
- RFIL $64,857,000.00
- ELEV N/A
- Revenue This Year
- RFIL $13.96
- ELEV N/A
- Revenue Next Year
- RFIL $5.83
- ELEV N/A
- P/E Ratio
- RFIL N/A
- ELEV N/A
- Revenue Growth
- RFIL N/A
- ELEV N/A
- 52 Week Low
- RFIL $2.86
- ELEV $0.50
- 52 Week High
- RFIL $5.77
- ELEV $5.83
- Technical
- Relative Strength Index (RSI)
- RFIL 52.25
- ELEV 43.44
- Support Level
- RFIL $5.15
- ELEV $0.64
- Resistance Level
- RFIL $5.67
- ELEV $0.72
- Average True Range (ATR)
- RFIL 0.33
- ELEV 0.05
- MACD
- RFIL -0.07
- ELEV -0.00
- Stochastic Oscillator
- RFIL 2.67
- ELEV 18.41
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.